Publications

5674 Results

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

Authors
KR Rai;BL Peterson;FR Appelbaum;JE Kolitz;L Elias;L Shepherd;JD Hines;GA Threatte;RA Larson;BD Cheson;CA Schiffer
Journal / Conference
New England Journal of Medicine 343(24):1750-1757
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

SELECT: The selenium and vitamin E cancer prevention trial rationale and design

Authors
EA Klein;IM Thomposn;S Lippman;P Goodman;D Albanes;PR Taylor;C Coltman
Journal / Conference
Prostate Cancer and Prostatic Diseases 3:145-151
Year
2000
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Fenretinide (FEN) vs placebo in postmenopausal breast cancer patients receiving adjuvant tamoxifen (TAM), an Eastern Cooperative Oncology Group Phase III Intergroup Trial (EB193, INT-0151)

Authors
MA Cobleigh;R Gray;M Graham;L Norton;S Martino;GT Budd;JN Ingle;NE Davidson;WC Wood
Journal / Conference
Proc of the American Society of Clinical Oncology 19:86a(#328)
Year
2000
Research Committee(s)
Breast
Study Number(s)
SWOG-9514 (EB193)

Letter to the Editor: RE: RE: Chemoprevention of urological cancer

Authors
IM Thompson;CA Coltman
Journal / Conference
Journal of Urology 164(4):1321-1322
Year
2000
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Colon cancer survival is associated iwth increasing number of lymph nodes removed. a secondary analysis of INT-0089

Authors
TE Lo Voyer;ER Sigurdson;AL Hanlon;RJ Mayer;JS Macdonald;PJ Catalano;DG Haller
Journal / Conference
Proc of the American Society of Clinical Oncology 19:239a(#925)
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8899 (INT-0089)

Phase III study comparing three cycles of infusional BCNU/Cisplatin followed by radiation with radiation and concurrent BCNU for patients with newly diagnosed supratentorial glioblastoma multiforme (ECOG 2394 - SWOG 9508)

Authors
SA Grossman;A O'Neill;M Grunnet;M Mehta;J Pearlman;H Wagner;M Gilbert;H Newton;R Hellman
Journal / Conference
Proc of the American Society of Clinical Oncology 19:158a(#612)
Year
2000
Research Committee(s)
Brain
Study Number(s)
SWOG-9508

Phase II evaluation of interleukin-4 in patients with non-hodgkin's lymphoma: a Southwest Oncology Group trial

Authors
CW Taylor;M LeBlanc;RI Fisher;DF Moore, Sr;RW Roach;L Elias;TP Miller
Journal / Conference
Anti-Cancer Drugs 11:695-700
Year
2000
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9219

Minority recruitment in the prostate cancer prevention trial

Authors
CM Moinpour;JO Atkinson;SM Thomas;S Millon-Underwood;C Harvey;J Parzuchowski;LC Lovato;AM Ryan;S Hill;E DeAntoni;ER Gritz;IM Thompson, Jr;CA Coltman, Jr
Journal / Conference
Annals of Epidemiology 10(S8):S85-S91
Year
2000
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Increased incidence of mutations in the granulocyte-colony stimulating factor receptor in patients with acute myeloid leukemia and chromosome 7 abnormalities without antecedent severe congenital neutropenia.

Authors
LJ Druhan;AC Lidral;CL Willman;ML Slovak;KJ Kopecky;BR Avalos
Journal / Conference
Blood 96(11):83a(#354)
Year
2000
Research Committee(s)
Leukemia

A phase III randomized intergroup trial of subtotal lymphoid irradiation (STLI) versus doxorubicin, vinblastine, and STLI for stage IA-IIA Hodgkin's disease (SWOG 9133, CALGB 9391)

Authors
OW Press;M LeBlanc;A Lichter;TH Wassermann;T Miller;R Fisher
Journal / Conference
Blood 96(11):575a(#2471)
Year
2000
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9133